Alogliptin (NESINA), a dipeptidyl peptidase IV (DPP-4) inhibitor, was approved by the FDA on January 25, 2013 to improve blood sugar control in adults with type 2 diabetes. This drug had been ...

The enzyme dipeptidyl peptidase-4 (DPP-4) prevents the inactivation of glucagon-like peptide-1 (GLP-1). Since GLP-1-based therapy is a promising novel treatment of type 2 diabetes, the strategy to ...

Egypt: A recent randomized controlled trial has demonstrated that sitagliptin, a DPP-4 inhibitor, significantly improves ...

The Director of Public Prosecutions (DPP) has officially withdrawn all charges against former Mungiki leader Maina Njenga. The announcement was made by Njenga’s lawyer Ndegwa Njiru on Monday, November ...

Two men each facing 23 charges in respect of alleged possession of firearms and ammunition will be tried on indictment in the ...

To have enough sway to pass legislation going forward, the ruling bloc has asked for help from the Democratic Party for the ...

To have enough sway to pass legislation going forward, the ruling bloc has asked for help from the Democratic Party for the ...

Use of sodium glucose cotransporter 2 (SGLT-2) inhibitor drugs to treat type 2 diabetes may also help to lower the risk of ...

The Bank of Japan shouldn’t raise interest rates again before March next year, according to Yuichiro Tamaki, a potential key ...

New research presented at the ACG Annual Meeting suggests that GLP-1RAs lower the risk of pancreatic cancer in patients with ...

i.e. Ishiba may still win and a minority government may suffice with opposition DPP and JIP as partners on confidence and ... Resistance here at 154.80 (recent high) and 156.50 (76.4% fibo). Support ...

The Bank of Japan should avoid overhauling its ultra-loose monetary policy now, the head of a kingmaker opposition party said ...